ARTICLE | Financial News
Chiron lowers Fluvirin, EPS guidance
June 16, 2005 1:29 AM UTC
On Wednesday, CHIR was down $2.48 to $35.47 on 6.4 million shares after the company lowered its 2005-06 production estimates for Fluvirin influenza vaccine and its 2005 EPS guidance. CHIR now expects ...